DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Equity Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
A••••••• C•••••• M••••••••• L•
Fund of fundsClassification probableLower middle marketSEC registered investment adviser· New York, NYa•••••••.com
••• Locked
As of · identity and classification; each section below carries its own date
- Regulatory AUM
- $2.9B
- PE fund assets
- $102M
- PE funds
- 1
- Investments held
- 0 of 87
- Deals, last 12 months
- Not established
Form ADV
Form ADV
Form ADV
DFX transaction tape
As of · identity and classification; each section below carries its own date
Why this matters
- Sectors healthcare
- Graphs 2
- RAUM $2.9B
Classification
How this organization is classified, and on what basisFund of funds · 1 in historyShowHide
- Class
- Fund of fundsprobable, confidence 75%
- Basis
- R1: 1 of 1 admitted vehicles carry the sworn fund-of-funds flag
- Size band
- Lower middle marketdefined by: proxy: $0.10bn Private Equity Fund GAV on the Form ADV filed 2024-09-10
Classification history (1)
- Sep 13, 2026Fund of funds (probable, 75%, cls-pe-1)R1: 1 of 1 admitted vehicles carry the sworn fund-of-funds flag
Regulatory footprint (Form ADV)
- Adviser type
- registered investment adviser
- Form ADV filings
- Feb 14, 2012 to Sep 10, 2024
- RAUM
- $2.9Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 1
- PE fund GAV, latest filing
- $102Mreported gross assets (Form ADV), not fund size
- All private fund GAV
- $2.9Bevery private fund type, latest filing
- 2024 PE fund GAV
- $102Msum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 11%
- Fund type mix
- filed 2024-09-10, latest gav Hedge Fund $2.8B, Private Equity Fund $102M, latest counts Hedge Fund 7, Private Equity Fund 1, lifetime distinct Hedge Fund 8, Private Equity Fund 1
- Employees
- 24
- Headquarters
- New York, NY
- Office address
- ••• Locked
- Business phone
- ••• Locked
Stated criteria beside observed behaviour
87 observed deals
Stated by the firm
- Sectors
- healthcare
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- not stated or not yet read
- Thesis
- not stated or not yet read
Observed from deals on record
- roles
- unknown 87
- period
- to unknown, from unknown, undated holdings 87, dated observations 0
- window
- last unknown, first unknown
- control
- unknown 87
- companies
- 87
- geography
- investments
- 87
- seller kinds
- transactions
- 0
- cadence by year
- platform add on
- add ons 0, platforms 0, add ons per platform unknown
- sector known for
- 12
- disclosed value usd
- n 0
- sector distribution
- count 6, share 0.069, value life sciences, examples Agendia, Universal Biosensors, Verenium Corporation, Puma Biotechnology, count 6, share 0.069, value healthcare services, examples Vita Health, Sound Physicians, Upstream Rehabilitation, Tecomet
- holding period years
- n 0
- repeat counterparties
- subsector distribution
- count 6, share 0.069, value life sciences, examples Agendia, Universal Biosensors, Verenium Corporation, Puma Biotechnology, count 2, share 0.023, value outpatient specialty clinics, examples Tecomet, Company AQUA Dermatology, count 1, share 0.011, value outpatient mental health substance, examples Vita Health, count 1, share 0.011, value other ambulatory, examples Sound Physicians, count 1, share 0.011, value physical occupational therapy, examples Upstream Rehabilitation, count 1, share 0.011, value veterinary, examples Company Heartland Veterinary Partners
87 companies on the graph (0 transactions); most in life sciences (6); no dated observations
Funds
1 on record
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| A••••••• O••••••••• I• C•••••••• a• L• ADV: Private Equity Fund | Co-investment vehicle | 2021 first reported on Form ADV | $102M as of Sep 10, 2024 | no Form D | Unknown |
Team
13 current, 2 former
Managing partner (2)
- J•••••• A•••• F•••••• · Managing Member · since Sep 1, 2014 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- J•••••• A•••• F•••••• · Managing Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Partner (2)
- L•••••• D• H••••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- M••• K••••••• · Partner · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Principal (1)
- A•••• P•• · Principal · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Vice president (4)
- A••••• C••••• H•••• · Senior Vice President And Secretary · since Jan 1, 2015 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- C••••••••• H•••• · Senior Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- E••• M•••••• S••••• · Senior Vice President · since Jul 1, 2024 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- R•••••• J• A•••• · Vice President · since Nov 1, 2020 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
Associate (3)
- A••• B••••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- R••• E••••• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
- Y••••• M•• · Associate · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
Platform (1)
- C••••••• A••• H••••••••• · Vice President And Assistant Secretary · since Jan 1, 2015 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
2 former (kept with end dates)
- J••••• D•••• L••• · Member · Jan 1, 2015 to Sep 10, 2024 Inference
- P••• A•••••• W•••••••• · Senior Vice President · Jan 1, 2015 to Jul 26, 2024 Inference
Portfolio
87 relationships, 0 platforms, 0 add-ons
Transactions
0 on record
No transaction naming this firm has been collected yet. The deal tape is read from SEC filings and cited announcements.
Placement agents, lenders, advisers and co-investors
0 relationships
No counterparty collected yet. These are counted from transactions that name both this firm and the other party, and from placement agents on this firm’s funds.
LP commitments
0 disclosed
No LP commitment collected yet. An LP edge needs a public disclosure with a quote, such as a pension plan’s report or an announcement naming the LP.
Events
50 most recent
- Apr 2, 2026A••••••• C•••••• M••••••••• and E••••••• Enter Into $50 Million Japan Royalty Financing to Support Strategic A••••••••• of Corstasis T•••••••••
- Jan 5, 2026Global Expansion with Strategic Investment and Alliance with a Leading U.S. MedSpa Platform OrangeTwist as Part of Broader Growth Strategy
- Aug 4, 2025U• W•••••••• C•••••••s A••••••••• ofAdaptimmune’s Cell-Therapy Portfolio; Ensures Continued Patient Access to Tecelra and Advances Development of lete-cel
- Feb 6, 2025C•••• L••••••••• Announces Completion of A••••••••• of Revance T•••••••••
- Feb 5, 2025Signet H•••••care Partners, A••••••• C•••••• M•••••••••, Hildred Capital and P•••••science Inc. Announce Exit from P•••••ceutics International, Inc.
- Feb 4, 2025Jabil Acquires P••••••••• International, Inc
- Nov 6, 2024C••••• H••••• a• H••• Acquires Accentra
- Aug 12, 2024C•••• L••••••••• and Revance Announce Entry Into Merger Agreement
- May 25, 2022u••••• Announces $25.5m Investment from Fund Managed by A••••••• C•••••• M•••••••••
- Mar 21, 2022Revance Closes on $300 Million Note Purchase Agreement with A••••••• C•••••• M•••••••••
- Jun 30, 2021Anthem, Inc. C•••••••s A••••••••• of MMM Holdings, LLC and Affiliates From I••••••••• H•••••, L.P.
- Jun 8, 2021Deerfield H•••••care Technology A•••••••••s Corp. Announces Closing of Business Combination With C••••••
- May 5, 2021A•••• P••••• to Acquire Chiasma, Inc. to Further Strengthen Global Leadership in Rare and Orphan Diseases
- Feb 2, 2021Anthem, Inc. to Acquire MMM Holdings, LLC and Affiliates From I••••••••• H•••••, L.P.
- Jan 6, 2021Walgreens Boots Alliance Accelerates V•••••••• Investment and Large-Scale Rollout of Primary Care Clinics
- Dec 18, 2020Deerfield H•••••care Technology A•••••••••s Corp. Announces Proposed Business Combination to Form C••••••
- Nov 18, 2020A•••••• and Paige Announce Landmark Strategic Partnership to Revolutionize Treatment P•••ning in Breast Cancer
- Sep 30, 2020S••••• B•• C•••••••s A••••••••• of Global Rights to Oncology Drug Copiktra®
- Mar 4, 2020Asahi Kasei C•••••••s A••••••••• of V•••••• P••••••••• Inc.
- Jan 10, 2020Lilly Announces Agreement to Acquire D••••••
- Sep 25, 2019A•••• P••••• plc Announces Completion of the A••••••••• of Aegerion P•••••••••, Inc.
- Jul 25, 2018A•••••• Secures $35 Million Investment from Funds Managed by A••••••• C•••••• M•••••••••
- Jun 4, 2018Gryphon Investors Announces Majority Investment in Water's Edge D•••••••••
- Dec 22, 2017C••••••• S•••• C•••••••s A••••••••• of Prodisc Assets
- Feb 2, 2017Comvest Announces A••••••••• of Interamerican M•••••• Center Group
- Sep 8, 2016A••••• E••••••••• and Lpath Sign Merger Agreement
- Jul 21, 2016Galenica to Acquire R•••••• to Strengthen its Business Unit, Vifor P•••••
- May 23, 2016A•••• P••••••••• to Acquire XenoPort
- Mar 3, 2016A•••••• Announces A••••••••• to Expand U.S. Business
- Apr 29, 2015Progenity Acquires Carmenta Bioscience for Proprietary Preeclampsia Technology
- Apr 13, 2015C••••• P••••••••• Announces U.S. Commercial Entry Through A••••••••• of INNOCUTIS
- Mar 18, 2015Retrophin to Acquire Rights to Cholbam from Asklepion P•••••••••
- Mar 5, 2015Mallinckrodt P••••••••• to Acquire I•••••, Inc. for $2.3 Billion
- Feb 27, 2015A••••• E••••••••• C•••••••s $50 Million Financing
- Jan 5, 2015V•••••• Signs an Agreement to Acquire Dukoral® Vaccine
- Dec 5, 2014T••••••, Inc. Acquires Symmetry M•••••• OEM Solutions Business
- Sep 19, 2014Horizon P••••• C•••••••s A••••••••• of Vidara T••••••••• International
- Aug 19, 2014P••••• T••••••••• Closes on A••••••••• of Treximet. Raises $220m Senior Notes
- Jul 16, 2014Pfizer to Acquire I•••••••••, Inc.
- Jul 1, 2014Retrophin Closes $91 Million Financing
- Mar 5, 2014Merger of CCBR-SYNARC and B•••••••••, Inc.
- Feb 5, 2014P••••• Attracts $65 Million Institutional Investment
- Dec 24, 2013Madison Dearborn Partners to Acquire I•••••
- Nov 13, 2013I••••••••• Inc. C•••••••s $20 Million Term Loan Facility
- Sep 20, 2013V••••••• Enters Agreement to be Acquired by BASF
- Sep 3, 2013bioMerieux to Acquire B•••••• D••••••••• for $450 Million Plus Net Financial Debt
- Jan 4, 2013I••••••• C•••••••s $175 Million Debt Offering
- Feb 14, 2012A••••••• C•••••• M••••••••• L• first filed Form ADV in the extract (IA)
- Oct 6, 2010M••••• S••••• P••••••• C•••••••s Second Royalty Monetization Transaction
- Sep 1, 2010M••••• S••••• P••••••• C•••••••s Royalty Monetization Transaction
Across the graphs
A••••••• C•••••• M••••••••• L• is the same institution as 2 records in Independent Sponsors and RIA and Wealth.
Independent Sponsors1RIA and Wealth1
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…